14 Lymphoma Clinical Trials in Stanford, CA (2026)

Q: How do I join a clinical trial in Stanford?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Stanford research site will contact you.

Recruiting Lymphoma Studies in Stanford

NCT00398177Recruiting

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma....

Stanford, CA9,999 participantsStanford University

View Study Details

NCT04685616Recruiting

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

RADAR is a multicentre, international, randomised, open-label phase III clinical trial composed of 2 trials running in parallel. Trial 1 will be led and sponsored by University College London (UCL) an...

Stanford, CAPHASE31,042 participantsUniversity College, London

View Study Details

NCT05978141Recruiting

A Registry for People With T-cell Lymphoma

The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Researchers will use the information from this database to learn more a...

Stanford, CA1,000 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT03964480Recruiting

Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.

This study T-Cell Project 2.0 is based on the former International PTCL study designed by the International T-cell Non-Hodgkin's Lymphoma Study Group (T-Cell Project 1.0: Prospective Collection of Dat...

Stanford, CA1,000 participantsAssociazione Angela Serra per la ricerca sul cancro

View Study Details

NCT07479797Recruiting

Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy

The goal of this clinical study is to compare the study drug KITE-753 versus axicabtagene ciloleucel (axi-cel) in adult participants with relapsed or refractory (r/r) large B-cell lymphoma (LBCL) afte...

Stanford, CAPHASE3550 participantsKite, A Gilead Company

View Study Details

NCT04792489Recruiting

DALY II USA/ MB-CART2019.1 for DLBCL

DALY II USA is a phase II, multi-center, single arm study to evaluate the efficacy, safety, and pharmacokinetics of zamtocabtagene autoleucel (MB-CART2019.1) in patients with relapsed and/or refractor...

Stanford, CAPHASE2315 participantsMiltenyi Biomedicine GmbH

View Study Details

NCT03618550Recruiting

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

The purpose of this study is to test any good and bad effects of the study drug, pembrolizumab, in combination with GVD in the treatment of Hodgkin lymphoma....

Stanford, CAPHASE2257 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT04989803Recruiting

Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma

The goal of this clinical study is to learn more about the safety and effectiveness of the study drugs, KITE-363 and KITE-753, in participants with relapsed and/or refractory B-cell lymphoma....

Stanford, CAPHASE1247 participantsKite, A Gilead Company

View Study Details

NCT07439653Recruiting

A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

A Phase 1/2 study to evaluate safety, tolerability, and anticancer activity of TORL-5-700 as a monotherapy and in combination in R/R NHL...

Stanford, CAPHASE1155 participantsTORL Biotherapeutics, LLC

View Study Details

NCT06116110Recruiting

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

This is an observational long-term follow-up (LTFU) study for subjects who previously received zamtocabtagene autoleucel, known as MB-CART2019.1....

Stanford, CA150 participantsMiltenyi Biomedicine GmbH

View Study Details

NCT06553872Recruiting

Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL

This is a phase 2, open-label, randomized, multicenter clinical trial in patients with relapsed/refractory mantle cell lymphoma (R/R MCL) who meet the criteria for standard-of-care FDA label for CD19 ...

Stanford, CAPHASE260 participantsH. Lee Moffitt Cancer Center and Research Institute

View Study Details

NCT06733441Recruiting

A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma

The primary purpose of this study is to evaluate the anti-tumor activity of TLN-254 monotherapy in participants with relapsed or refractory T-cell lymphoma....

Stanford, CAPHASE150 participantsTreeline Biosciences, Inc.

View Study Details

NCT05370430Recruiting

BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

A Phase 1 Study Evaluating BAFFR-targeting CAR T Cells for Patients with Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma (B-NHL)...

Stanford, CAPHASE136 participantsPeproMene Bio, Inc.

View Study Details

NCT06510361Recruiting

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

This research is being done to see if epcoritamab is effective in treating follicular lymphoma as a second line of treatment. The name of the study drug in this research study is: -Epcoritamab (a ty...

Stanford, CAPHASE235 participantsBeth Israel Deaconess Medical Center

View Study Details

About Lymphoma Clinical Trials in Stanford

Lymphoma is a cancer of the lymphatic system that affects infection-fighting cells called lymphocytes. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment often includes chemotherapy, radiation, immunotherapy, and in some cases stem cell transplant.

There are currently 14 lymphoma clinical trials recruiting participants in Stanford, CA. These studies are seeking a combined 14,896 participants. Research is being sponsored by Stanford University, University College, London, Memorial Sloan Kettering Cancer Center and 8 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lymphoma Clinical Trials in Stanford — FAQ

Are there lymphoma clinical trials in Stanford?

Yes, there are 14 lymphoma clinical trials currently recruiting in Stanford, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Stanford?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stanford research site will contact you about next steps.

Are clinical trials in Stanford free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stanford studies also compensate for your time and travel.

What lymphoma treatments are being tested?

The 14 active trials in Stanford are testing new therapies including novel drugs, biologics, and treatment approaches for lymphoma.

Data updated July 17, 2026 from ClinicalTrials.gov